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An important role for plexinD1 in thymic development is inferred from studies of germline
Plxnd1 knockout (KO) mice where mislocalized CD69+ thymocytes as well as ectopic
thymic subcapsular medullary structures were observed. Given embryonic lethality of the
Plxnd1−/− genotype, fetal liver transplantation was employed in these prior analyses. Such
embryonic hematopoietic reconstitution may have transferred Plxnd1 KO endothelial and/or
epithelial stem cells in addition to Plxnd1 KO lymphoid progenitors, thereby contributing to
that phenotype. Here we use Plxnd1flox/flox mice crossed to pLck -Cre, pKeratin14-Cre, or
pTek -Cre transgenic animals to create cell-type specific conditional knockout (CKO) lines
involving thymocytes (D1ThyCKO), thymic epithelium (D1EpCKO), and thymic endothelium
(D1EnCKO), respectively. These CKOs allowed us to directly assess the role of plexinD1
in each lineage. Loss of plexinD1 expression on double positive (DP) thymocytes leads
to their aberrant migration and cortical retention after TCR-mediated positive selection. In
contrast, ectopic medulla formation is a consequence of loss of plexinD1 expression on
endothelial cells, in turn linked to dysregulation of thymic angiogenesis. D1EpCKO thymi
manifest neither abnormality. Collectively, our findings underscore the non-redundant roles
for plexinD1 on thymocytes and endothelium, including the dynamic nature of medulla
formation resulting from crosstalk between these thymic cellular components.
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INTRODUCTION
The plexins encode large (∼200 kDa) transmembrane glycopro-
teins with domain similarity to the scatter factor receptors encoded
by the MET gene family and RON receptor tyrosine kinases (1).
There are four plexin families (plexin-A, -B, -C, -D) that function
as receptors for multiple subfamilies of semaphorins, sometimes
in the context of neuropilin-1, and neuropilin-2, to control cell
dissociation or attachment, and repulsion or attraction in a vari-
ety of tissue types. Approximately 20 vertebrate semaphorins
are known, classified in five distinct subfamilies of secreted and
surface-bound proteins (1). In the nervous system, the effects of
secreted semaphorin-plexin interaction on axonal pathfinding are
generally repulsive (1). The cytoplasmic domain of each plexin
contains a GTPase activation domain (GAP) of ∼600 aa encom-
passing a central Rac- or Rho-like binding motif (RBD) (2, 3).
These domains have been shown to interact with and regulate
the activity of a number of small GTPases including direct bind-
ing of Rac1, Rnd1, and RhoD to the RBD and less-well defined
sequestration of, or GAP activity against, R-Ras and Rap fam-
ily members (4–6). The end result is often an effect upon cell
motility including an extensive crosstalk with integrin-mediated
adhesion (7–9).
In addition to neural development (10), plexinD1 was previ-
ously reported to be important in angiogenesis and cardiovascular
development (11, 12) with consequent effects upon bone vascu-
larization and skeletogenesis (13, 14). In addition, lymphoid traf-
ficking including migration of thymocytes (15) and movement of
B cells into germinal centers (16) is regulated by plexinD1. Specif-
ically, with respect to thymocytes, it is the cortical to medullary
trafficking of the positively selected double positive (DP) thymo-
cytes which is disrupted in cells lacking plexinD1 (15). Repop-
ulation of irradiated Ly5 congenic mice with fetal liver-derived
hematopoietic stem cells from germline knockout (KO) plexinD1
(Plxnd1−/−) mice resulted in developing CD69+ DP thymo-
cytes that exhibited aberrant trafficking following TCR activation
(15). In contrast to DP thymocytes arising from wild-type (WT)
transplanted fetal liver progenitors, a large fraction of Plxnd1−/−
post-selection CD69+ DP thymocytes did not migrate toward the
medulla as they further differentiate but rather remained in the
cortex. Thymi reconstituted with Plxnd1−/− hematopoietic prog-
enitors also manifest abnormal ectopic medulla formation, with
medullary foci primarily localized to the subcapsular zone.
While recent data showing that the plexinD1 signaling path-
way controls both the surface topology of β1 integrin nanoclusters
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and individual integrin catch bonds readily account for the thy-
mocyte migratory defect (manuscript submitted), the basis of
the ectopic medulla formation is unclear. The role of plexinD1
in determining thymic medullary morphogenesis is complicated
by its essential regulation of endothelial cell branching during
angiogenesis (11, 12, 14), a process of critical importance to
thymic structure, impacting entry, and egress of lymphoid cells
as well as thymic tissue oxygenation (17–19). Sema3E, a solu-
ble secreted molecule whose primary source within the thymus
is the medulla, is the physiological ligand of plexinD1 (15).
It is through interaction with plexinD1 that sema3E has been
demonstrated to regulate vascular endothelial branching in var-
ious tissues (20). Developmental analysis of Plxnd1 and Sema3e
germline deletion embryos reveals defects in aorta-pulmonary
artery large vessel separation (truncus arteriosus) in Plxnd1−/−
animals but not in the Sema3e−/− animals, implying a cardio-
vascular developmental function for plexinD1 distinct from its
sema3E ligand (11). Supporting the complexity of plexinD1 func-
tion in angiogenesis, VEGF regulates plexinD1 to limit expression
to the front of actively sprouting blood vessels where further sig-
naling may or may not occur dependent upon the relative presence
of sema3E (21, 22).
In this report, we analyze the contributions of plexinD1 in
differing cellular thymic compartments that collectively foster
thymocyte development. Since germline Plxnd1 deletion is embry-
onic lethal and thymic reconstitution with stem cells derived
from fetal liver may include endothelial progenitors with angio-
genic potential as well as other progenitors with epithelial cell
potential (23–25), we undertook a systematic analysis of condi-
tional knockout (CKO) mice where cell-specific Plxnd1 deletion
allowed development on an otherwise normal B6 background.
This strategy permitted us to delineate the functional spheres
of operation of plexinD1 within the thymus. Three different
Plxnd1flox/flox models were developed where transgene expres-
sion of Cre recombinase from the pLck promoter (26) in one
resulted in deletion of Plxnd1 during thymocyte development,
expression of Cre recombinase from the pKeratin14 promoter
(27) in a second resulted in deletion of Plxnd1 in thymic epithe-
lial cells (TEC), and expression of Cre recombinase from the
pTek promoter (28) in a third resulted in deletion of Plxnd1
in endothelial cells. Using these mouse models, we have deter-
mined that loss of plexinD1 expression in thymocytes per se leads
to the aberrant migration and cortical retention of CD69+ DP
cells. On the other hand, ectopic subcapsular medullary formation
results from loss of plexinD1 expression on the endothelial cells
involved in vascular angiogenesis. Our results provide functional
insight into the interplay of angiogenesis, thymocyte maturation,
and thymic epithelial cell development in orchestrating T lineage
differentiation.
MATERIALS AND METHODS
ANTIBODIES AND REAGENTS
AnnexinV-FITC, anti-FcγR (2.4G2), anti-CD69-FITC, anti-
CD25-PE-Cy7, anti-CD44-APC-Cy7, anti-CD8α-FITC, and anti-
CD4-APC were obtained from BD-Pharmingen (San Jose, CA,
USA). Anti-ESAM-FITC and anti-MHCII (clone M5/114.15.2;
anti-I-A/I-E) was obtained from eBioscience. ER-TR5 was pro-
vided by Dr. W. van Ewijk (Leiden University Medical Cen-
ter, Netherlands), UEA1-FITC was obtained from Sigma-Aldrich.
TROMA1 (anti-Keratin8 mAb) clone was obtained from Develop-
mental Studies Hybridoma Bank (Iowa City, IA, USA). Sema3E-Fc
was produced as described previously (15); note that the Fc is a
mouse γ2c isotype. PE-conjugated F(ab′) anti-mouse γ2c heavy
chain and IgG2c control antibody was obtained from Jackson
Immunoresearch (West Grove, PA, USA). 145.2C11 mAb was
purified directly from hybridoma culture media using Gamma-
bind Plus (GE HealthCare, NJ, USA) and dialyzed against PBS and
adjusted to a final concentration of 2 mg/ml.
FLOW CYTOMETRY
Cell numbers were enumerated using a C-chip hemocytometer
(NanoEntek, Korea). In general, single cell suspensions (2× 106
total) were blocked with 2.4G2 Ab and stained with anti-CD4-APC
mAb, anti-CD8α-FITC, anti-CD25-PE-Cy7, anti-CD44-APC-Cy7
mAb, and purified sema3E-Fc (5µg/ml) for 15 min. After wash-
ing with PBS, the cells were stained with anti-mouse IgG2c-PE
to detect bound sema3E-Fc for an additional 15 min. After wash-
ing with PBS, the cells were resuspended in PBS and analyzed as
described previously (15).
APOPTOSIS ANALYSIS
One million total thymocytes were stimulated for up to 72 h on
plates pre-coated with anti-CD3ε mAb (clone 145.2C11). After
incubation, the cells were harvested and stained with anti-CD4-
APC/anti-CD8α-PE/anti-TCRβ-FITC mAbs and analyzed by flow
cytometry. The percentage viable DP thymocytes relative to input
at t = 0 was then determined.
HISTOLOGY, IMMUNOHISTOLOGY, AND CONFOCAL MICROSCOPY
All the staining procedures were performed as described previ-
ously (15). Histological sections were stained using a standard
hematoxylin and eosin procedure. In general, adjacent cryosec-
tions from thymi of 3- to 4-week-old WT, D1ThyCKO, D1EpCKO,
and Sema3e−/− mice were stained with the anti-CD4-APC/anti-
CD8α-TRITC mAbs for delineation of cortex from medulla
and with anti-CD69-FITC, and MHCII-FITC or UEA1-FITC as
required. ER-TR5 (rat IgM) was visualized using anti-rat IgM-
FITC. Images were obtained using a Zeiss LSM700 confocal laser-
scanning microscope with 40× oil lens for objective lens (Carl
Zeiss MicroImaging, NY, USA). H&E staining images were taken
using a Nikon Eclipse Ti-S microscope with 4× dry lens for
objective lens (Nikon Instruments, Inc., NY, USA). In every case,
images were taken in monochrome to maximize resolution and
then digitally recolored prior to merging of images. For identifica-
tion of Pecam1 on developing endothelial structures, thymi from
newborn WT and D1EnCKO mice were collected and fixed in
10% formalin overnight. Paraffin sections prepared from the fixed
thymi were stained with anti-Pecam1 antibody and, after washing
the sections were mounted with DAPI counterstaining the nuclei.
In these images, high density nuclear DAPI staining corresponded
to cortical regions and lower density staining corresponded with
medullary regions.
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MICE AND FETAL THYMI TRANSPLANTATION
pLck-Cre, pKeratin14-Cre, and pTek-Cre mice were purchased from
Jackson Laboratory. The genotyping primers were synthesized by
Eurofins. PCR reactions for detection of Cre gene detection were
performed as recommended by the Jackson Laboratory. Each Cre
strain was backcrossed onto Plxnd1flox/flox background. Since the
D1EnCKO mice were neonatal lethal, D1EnCKO or WT fetal
thymi were prepared at embryonic day 16.5–17.5 and kept in
sterile cold PBS. At this age, WT thymic lobes are fused to form
one thymus with two lobes whereas D1EnCKO thymic lobes are
not fused. After anesthetizing recipient mice using ketamine and
xylazine, fetal thymi were transplanted under the renal capsule
through a 0.5 cm cut in the skin. For WT transplants serving as
controls, the complete thymus with two lobes was transplanted
whereas for the D1EnCKO transplants, a single lobe was trans-
planted. After transplantation, the skin portal was closed using
sutures. Following surgery, the cages with mice were warmed
using hot packs until the mice recovered consciousness. Four
weeks later, the thymi developing under the kidney capsule kid-
ney were collected and immersed in OTC for cryosectioning. All
the animal experiments were performed under animal protocols
approved by Dana–Farber Cancer Institute and Harvard Med-
ical School Animal Care and Use Committee Institutional Review
Boards.
WESTERN BLOTTING
Protein extract from total thymocytes was prepared with IP buffer
[1% NP40, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, plus pro-
tease inhibitor cocktail (Roche, Germany)]. Lysate protein con-
centrations were determined using the BCA Protein Assay Kit
(Pierce, IL, USA). Total lysate proteins were separated by SDS-
PAGE (10%), transferred to PVDF, blocked overnight using TBS-T
containing BSA (1%), blotted with anti-plexinD1 antisera (Sigma–
Aldrich, MO, USA) followed by anti-rabbit-HRP secondary anti-
body (Invitrogen, CA, USA), and detection by chemiluminescence
(ECL system; Amersham, VA, USA).
STATISTICAL ANALYSIS
Data are presented as mean values± one standard error (SE). P
values were calculated using Student’s t -test.
RESULTS
GENERATION OF MICE WITH A THYMOCYTE-SPECIFIC PlxnD1 CKO
(D1ThyCKO)
Given that plexinD1 is operative in multiple developmental
processes as described above, the T lineage autonomous effects of
the germline Plxnd1 KO contributing to the previously observed
thymic phenotype versus non-T cell lineage cell expression of
Plxnd1 remained to be determined (15). Accordingly, a thymocyte-
specific Plxnd1 CKO mouse strain, termed D1ThyCKO, was cre-
ated. To this end,Plxnd1flox/flox mice generated with loxP sequences
flanking the first exon encoding the transcription initiation site
and 5′ sequence encoding the sema domain of the Plxnd1 allele
(14) were backcrossed with B6 mice multiple times (n> 10) to
establish a B6 background. Next, these B6 Plxnd1flox/flox mice
were crossed with pLck-Cre transgenic B6 mice expressing a Cre
recombinase under the control of the T cell-specific pLck pro-
moter. Finally, offspring of these mice were intercrossed to yield
the D1ThyCKO animals.
In contrast to germline Plxnd1−/− KO animals, the D1ThyCKO
mice were viable and healthy, despite elimination of plexinD1
expression during T cell development. Absence of plexinD1 pro-
tein was evident both from Western blotting analysis of thymus
lysates from these animals (Figure 1A) as well as by FACS analysis
of their DP thymocyte surface plexinD1 expression detected by
specific binding of sema3E-Fc (Figure 1B). On the other hand,
plexinD1 was readily identified in WT samples. Despite the loss
of plexinD1 protein, D1ThyCKO thymic cellularity was identi-
cal to that of the WT, indicating that loss of plexinD1 does not
impact overall thymocyte expansion (Figure 1C). Further, the
major CD4−CD8− double negative (DN), CD4+CD8+ DP, and
CD4+ and CD8+ single positive (SP) thymocyte subpopulations
(defined by CD4 and CD8 expression) as well as progression
through the DN1-4 stages (defined by CD44 and CD25 expres-
sion) as shown in Figure 1D were equivalent in D1ThyCKO and
WT mice. Given that Plxnd1 gene transcripts and plexinD1 pro-
tein expression appear at the DP thymocyte level, it is of particular
note that the steady state expansions of DP and SP thymocytes in
both mice are comparable.
As shown in Figure S1B in Supplementary Material, CD69+
expression was indistinguishable on WT and D1ThyCKO DP cells,
suggesting that an equivalent number of thymocytes had under-
gone positive selection. In addition, the capacity of DP thymocytes
to undergo apoptosis induced by anti-CD3ε mAb in vitro was
identical (Figure S1A in Supplementary Material). Further, there
were no differences between WT and D1ThyCKO in transwell
migration assays responding to CXCL12 and CCL25 (Figure S2 in
Supplementary Material). Thus, by analysis of comparative phe-
notype, signaling, and response to chemokines in vitro, WT and
D1ThyCKO thymocytes appeared indistinguishable. Using global
thymic transcriptome analysis, we observed that the only gene
downregulated in D1ThyCKO thymocytes more than 10-fold is
Plxnd1 itself (data not shown). Accordingly, we attribute effects
observed in the subsequent thymic translocation of D1ThyCKO
cells in vivo during thymic organogenesis to loss of thymocyte
plexinD1.
DP THYMOCYTE PLEXIND1 EXPRESSION REGULATES CORTICAL TO
MEDULLARY TRANSLOCATION AFTER TCR ENGAGEMENT
We then ascertained whether the CD69+ post-selection
D1ThyCKO thymocytes exhibited the same cortical retention pat-
tern as we had observed previously using germline Plxnd1−/−
progenitors to repopulate Ly5 congenic animals post-transplant
(15). Cortex and medulla were identified using anti-CD4 and
anti-CD8 mAbs to define the medullary CD4 SP and CD8 SP
thymocytes as well as merged CD4/CD8 signals to define cortical
DP thymocytes (Figure 2). This delineation in the WT thymus
was confirmed by the strong medullary expression of MHC class
II and further confirmed by the medullary location for the ER-
TR5 marker (29, 30). Of note, in the WT thymus the CD69+
post-selection thymocytes exhibit a medullary location while in
the D1ThyCKO thymus, the CD69+ thymocytes are distributed
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FIGURE 1 | PlexinD1 is not expressed in D1ThyCKO thymocytes but
developmental progression is normal. (A) PlexinD1 was detected in total
thymocyte lysates from 3- to 4-week-old WT or D1ThyCKO mice (three
mice/strain) by Western blotting. The lower bands (**) are non-specific bands
common to both WT and D1ThyCKO thymocyte extracts and do not represent
plexinD1 (representative of four independent experiments). (B) PlexinD1
detected by binding of sema3E-Fc (blue line) or control IgG2c (red line) after
gating DP, CD4SP, CD8SP, and DN populations based on CD4 and CD8α
expression (representative of six independent experiments). (C)Total
thymocytes/thymus from WT or D1ThyCKO animals (n=10 for each strain;
P =0.737, not significant). (D)Thymocyte differentiation in WT and D1ThyCKO
mice. The percentage representations of DN (CD4−CD8−), DP (CD4+CD8+),
CD4SP (CD4+CD8−), and CD8SP (CD4−CD8+) are depicted (upper panels).
The percentages of DN1 (CD44hiCD25lo), DN2 (CD44hiCD25hi), DN3
(CD44loCD25hi), and DN4 (CD44loCD25lo) are shown (lower panels). Results
represent six independent experiments.
not only in the medulla but also throughout the cortex. This
phenotype is distinct from other lineage Plxnd1 CKO mice to
be described subsequently. Moreover, the ratio of medullary-
localized to cortical-localized CD69+ post-selection thymocytes
was enumerated (Figure 3A), confirming the cortical retention
D1ThyCKO thymus.
These results independently confirmed our original observa-
tion that plexinD1 expression in developing thymocytes plays an
important regulatory role in the cortical to medullary transloca-
tion of differentiating thymocytes following engagement of their
TCRs by self-pMHC on TEC. However, in contrast to the results
obtained with germline Plxnd1 KO progenitor transplant reconsti-
tution of the thymus, in the D1ThyCKO mice there is a completely
normal thymic cortex and medullary demarcation on histolog-
ical analysis (Figure 3B, upper panels) although at the level of
CD4 and CD8 display, the separation between cortical DP and
medullary SP thymocytes was less-well delineated, perhaps con-
sequent to the differentiation within the cortex of mislocalized
CD69+ cells (Figure 2), as previously observed with the germline
Plxnd1 KO mice (15). Furthermore, of note, the ER-TR5 and
MHCII markers also disengage from the dominantly medullary
location in WT thymus and now track with the cortically localized
CD69+ thymocytes in D1ThyCKO thymus (Figure 2). Quantita-
tion of the medullary to cortical ratio for ER-TR5 in wt thymus
(2.97± 0.35; Figure S4 in Supplementary Material) supports its
utilization as a relative medullary marker; likewise, the medullary
to cortical ratio for MHC class II (8.37± 0.82) also supports
its utilization as a medullary marker. In the D1ThyCKO thy-
mus, however, the medullary to cortical ratio for both ER-
TR5 and MHC class II was significantly reduced on compari-
son with wt thymus (1.39± 0.14 and 2.58± 0.54, respectively;
Figure S4 in Supplementary Material). UEA1, also considered
a medullary marker (31), does not segregate with ER-TR5 and
MHCII in the D1ThyCKO mice (Figure S3 in Supplementary
Material), instead remaining medullary in location. The alteration
in ER-TR5 and MHCII distribution in association with CD69+
thymocytes suggests possible crosstalk between developing thy-
mocytes and TEC. Interestingly, this disengagement of ER-TR5
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FIGURE 2 | CD69+ thymocytes are retained in the cortex in D1ThyCKO
and Sema3e−/− thymus but track to the medulla inWT and D1EpCKO
mice. For each strain, thymic frozen sections were stained for CD4 (green)
and CD8 (red) expression where the DP cells in the cortical regions appear
yellow in merged images due to the co-expression of CD4 and CD8. The
merged yellow DP signal was used to delineate the cortex (C) from the
individual SP red and green signals in the medulla (M) and a yellow dashed
line is inserted to indicate the apparent corticomedullary junction. A second
yellow dashed line indicates the capsule position. CD69 is an activation
marker expressed by positively selected thymocytes following TCR
stimulation. ER-TR5 is considered a medullary marker (29) while MHCII
(I-A/I-E) is preferentially expressed in medulla (30). Each figure is
representative of three independent experiments. White bar in the merged
images is 100µm.
FIGURE 3 | Loss of plexinD1 disrupts cortical to medullary
translocation of CD69+ DP thymocytes. (A)The regional distribution
of CD69+ cells in five separate frozen sections for each strain was
determined based on FITC signal intensity within the regions defined by
the apparent corticomedullary junction. After subtracting background
signal, the ratio of fluorescence signal strength between the cortex and
the medulla was calculated. A value >1 indicates stronger medullary
presence on comparison with cortex. Error bars represent SEM.
(B) Medullary structures were visualized by hematoxylin and eosin
(H&E) staining of WT, D1ThyCKO, and D1EpCKO thymi as well as in
thymus in irradiated animals repopulated with Plxnd1−/− fetal liver. The
red arrows in the Plxnd1−/− section indicate regions of fused thymic
medulla and capsule. Each figure is representative of three independent
experiments.
from medullary structures and association with CD69+ cortically
located DP thymocytes is recapitulated in the developing thymus
of Sema3e−/− mice (Figure 2). Hence, this phenotype is a result
of the direct disruption of sema3E-plexinD1 signaling in thymo-
cytes, since plexinD1 is normally expressed in the Sema3e-null
tissues (32).
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WHILE EPITHELIAL SPECIFIC PlxnD1 CKO (D1EpCKO) IS WITHOUT
THYMIC PHENOTYPE, TRANSIENT STIMULATION OF IMMATURE
(PRE-SP) THYMOCYTES ALTERS TEC DEVELOPMENTAL PROGRAMING
AND INITIATES MEDULLARY FORMATIONS
Since D1ThyCKO lacked any medullary abnormality detected
by histology, we next examined whether loss of plexinD1 in
the epithelial cell population may account for the aberrant
medullary phenotype observed by germline Plxnd1−/− progen-
itor repopulation of B6.SJL thymi. Here we used pKer14-Cre+
Plxnd1flox/flox (D1EpCKO) mice where activation of pKer14 during
the bipotential TEC progenitor stage (33) will lead to deletion
of Plxnd1 in descendant cTEC and mTEC. We found that the
D1EpCKO mice were viable and exhibited normal thymic devel-
opment and organization (Figure 2), histology (Figure 3B), and
thymocyte development (data not shown). The ratio of medullary
to cortical CD69+ thymocytes was∼4, directly comparable to that
for WT CD69+ thymocytes migrating to the medulla (Figure 3A).
Reinforcing the observed normal medullary development, in con-
trast to what was observed in D1ThyCKO mice, the ER-TR5 signal
in D1EpCKO thymus localized with UEA1 in medullary regions
comparable to that observed in WT thymus (Figure S3 in Sup-
plementary Material). Thus epithelial loss of plexinD1 neither
affected cortical to medullary migration of CD69+ thymocytes
nor medullary development.
Our results imply that CD69+ thymocytes are responsible for
the development of ER-TR5+ thymic signal and that ER-TR5 is
a marker linked to CD69+ thymocyte position as opposed to
medullary locale per se. This further implies that maturing DP thy-
mocytes following TCR stimulation may play a role in initiating
medullary development, a function previously ascribed exclusively
to mature SP T cells (34). It has been reported previously that
expression of αβ TCR transgenes, even on a non-selecting back-
ground, may induce ER-TR5+ medulla development suggesting
a role for αβ TCR induction of thymic medullary structures in
the absence of TCR activation (35). Since Tcrb+/+Rag2−/− mice
do not develop SP thymocytes or thymic medullary structures
(36, 37), constitutive pre-TCR expression is insufficient for induc-
tion of medulla. In such mice, T cell development is arrested at
the pre-TCR DP stage, but we reasoned that the pre-TCR and/or
incomplete surface CD3 heterodimers (38) on these thymocytes
might be stimulated via intravenous administration of anti-CD3ε
mAb (clone 145.2C11) that rapidly enters the thymus (39).
To determine whether the DP thymocytes could be activated
and induce medullary development, anti-CD3ε antibody was
injected into Tcrb+/+Rag2−/− mice and thymi were collected at 0,
6, 24, and 72 h to assess early activation and medulla development.
A final analysis was done at 3 weeks post-injection to determine
persistence and/or evolution of phenotypic changes. As shown in
Figure 4, by 24 h post-2C11 injection, distinct regions containing
CD4 and CD8 SP thymocytes were observed with extensive repre-
sentation of the ER-TR5 medullary marker, MHC class II expres-
sion and UEA1 expression together with increased representation
of CD69+ thymocytes. By 72 h, these developmental changes had
led to clear histological delineation of cortical and medullary
regions but the representation of SP cells was diminished. The
majority of cells were DP thymocytes and the ER-TR5 signal was
considerably weaker while the UEA1+ signal, correlating well with
areas of poor DP thymocyte representation, became even stronger.
This latter result suggests that ER-TR5 discriminates early sig-
nals delivered by CD69+ DP thymocytes from those inducing
development of UEA1+ mTEC, as observed for the disengage-
ment of ER-TR5 signal from that of UEA1 in the D1ThyCKO
FIGURE 4 | pre-TCR DP thymocytes can induce medullary formation on
activation. At time points from 0 h to 3 weeks, cryosections from thymi of
Tcrb+/+Rag2−/− mice injected at 0 h with anti-CD3ε mAb were prepared.
Adjacent cryosections were stained with anti-CD69 to identify activated DP
thymocytes, anti-CD4, and anti-CD8 to detect DP and SP thymocytes and
differentiate cortical from developing medullary structures, and with ER-TR5,
UEA1, and anti-MHCII (I-A/I-E) to identify putative medullary elements. Five
slides of each thymus were H&E stained. This experiment was repeated with
identical results. White bar in the merged images represents 100µm and the
black bar in the H&E panels represent 5 mm.
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and Sema3e−/− thymi where CD69+ thymocytes were retained in
the cortex (Figure 2 and Figure S3 in Supplementary Material). In
contrast, by 3 weeks after the single anti-CD3εmAb injection, both
ER-TR5 and UEA1 signals had diminished to almost undetectable
levels. All indications of medullary formation had disappeared
including histological demarcation of cortex and medulla, leading
to a set of images indistinguishable from those at time 0 h. Of note,
in every instance, the developing corticomedullary junction was
proximal to pre-existing larger vasculature defined by Endothelial
cell Selective Adhesion Molecule (ESAM) as shown in Figure S5
in Supplementary Material (40). One possibility is that 2C11 dis-
tribution from the vasculature is greatest at these sites to most
optimally trigger CD3 crosslinking on developing thymocytes.
ENDOTHELIAL CELL PLEXIND1 EXPRESSION IMPACTS THYMIC
MEDULLA LOCATION THROUGH REGULATION OF ANGIOGENESIS:
ANALYSIS OF D1EnCKO MICE
Although we had observed ectopic medullary formation in thymi
of B6.SJL mice repopulated in vivo by Plxnd1−/− fetal liver cells, no
such abnormality was observed in D1ThyCKO or D1EpCKO mice
where plexinD1 expression was specifically eliminated in thymo-
cytes or epithelial cells, respectively. We concluded that plexinD1
must be operating in a distinct non-hematopoietic, non-epithelial
lineage to impact thymic medullary developmental formation. In
this regard, it is well established that within the fetal liver there are
stem cells not only with lymphoid and myeloid potential but also
capable of differentiating into hepatocytes and biliary epithelial
cells (25, 41, 42). Further, the fetal liver tissue expresses endothelial
progenitor cells with angiogenic potential that may contribute to
thymic vascular development (23, 24). Since plexinD1 and sema3E
play a seminal role in controlling vascular endothelial branching
during development, the possibility that Plxnd1−/− endothelial
stem cells delivered in the fetal liver inoculate may have influenced
ectopic subcapsular medullary formation in our earlier report
required further elucidation (15). To address whether plexinD1
expression on endothelial cells contributes to vasculature pattern
formation, thereby supporting proper medullary formation, we
crossed Plxnd1flox/flox mice and pTek(Tie2)-Cre transgenic mice
expressing the Cre transgene in an endothelial-specific manner.
The resulting pTek-Cre+Plxnd1flox/flox (D1EnCKO) conditional
mice manifest a defect in separation of the aorta and the pul-
monary artery as previously reported and did not survive the
neonatal period (11, 14). Furthermore, the thymic lobes failed
to fuse, instead forming two separate thymic lobes on both sides
of the truncus artery as we observed for germline Plxnd1−/−
mice (15).
To overcome the neonatal lethality of D1EnCKO mice, we
transplanted excised fetal thymi under the renal capsule of
WT B6.SJL recipient mice. This procedure allows the thymus
carrying Plxnd1−/− endothelial cells to complete organogene-
sis (Figure 5A). After 3 weeks, the thymi with attached kid-
ney were excised and cryosections prepared for histological
analysis. The apposition of medulla to the thymic capsule was
clearly observed histologically in the D1EnCKO thymus explant
(Figure 5B). Analysis of sequential cryosections demonstrated
that these medullary structures contained predominantly CD4
SP thymocytes and stained with the ER-TR5 medullary marker
(Figure 5B inset).This medullary structure is distinct from the
cortical region otherwise marked by Troma1 (anti-cytokeratin 8),
a cTEC-expressed protein. In contrast, CD4 SP thymocytes are not
present in the cortical subcapsular region of WT thymus where
the merged signal of CD4 and CD8 on DP thymocytes dominated
(Figures 2 and 5C).
To next determine whether these abnormal subcapsullary
medullary formations were related to vascular development,
we examined the expression of the vascular ESAM marker for
significant differences between the WT and D1EnCKO thymi.
In WT thymus, the ESAM signal was detected at highest levels
on both sides of the corticomedullary junction with little rep-
resentation in the outermost cortex (Figure 5C and Figure S6
in Supplementary Material). In contrast, in the D1EnCKO thy-
mus the ESAM signal was broadly spread throughout the cortical
region with strongest representation in the subcapsular area and
less of a medullary presence (Figure 5C). The regulatory func-
tions of plexinD1 for vascular endothelial branching are initiated
by binding its ligand sema3E, leading us to examine whether a
similar pattern of ESAM+ vascular structures was present in the
Sema3e−/− thymus. As shown in Figure 6 and Figure S6 in Supple-
mentary Material, unlike the pattern in the D1EnCKO thymus, the
ESAM signal was broadly distributed throughout the Sema3e−/−
thymus without subcapsular representation implying that some
functionality of plexinD1 in thymic vascular pattern formation
is apparently sema3E-independent. Certainly, no difference was
observed in the distribution of vascular ESAM+ signal around the
corticomedullary junction in WT and D1ThyCKO thymus (Figure
S6 in Supplementary Material), implying the ectopic medullary
formations may be related to the effects of plexinD1 and sema3E
upon thymic vascular bed development. Conversely, the distribu-
tion of CD69+ thymocytes in the D1EnCKO thymus clearly shows
a strong medullary presence of CD69+ cells. Although there is
collection of CD69+ cells around the corticomedullary junction,
this did not translate into an overt retention of CD69+ cells in
the cortex (Figure S7 in Supplementary Material) and a normal
medullary structure with appropriate localization of MHC class
II, ER-TR5, and mTEC-expressed UEA1 and a clearly demarcated
corticomedullary junction (Figure S7 in Supplementary Mater-
ial). Consequently, loss of plexinD1 on the thymic endothelial
cell population does not affect CD69+ thymocyte translocation
from the cortex to the medulla but it does seem to alter cortical
and medullary vascular development in a sema3E-independent
manner.
To demonstrate that the development of D1EnCKO fetal thy-
mus under recipient renal capsules properly represented the devel-
opment ongoing in D1EnCKO, we analyzed thymi from new-
born D1EnCKO mice using anti-Pecam1 (Platelet Endothelial
Cell Adhesion Molecule-1, CD31) mAb that identifies vascular
endothelial cells including those in newly formed vasculature (43)
(Figure 5D and Figure S8 in Supplementary Material). In WT
thymi the Pecam1 signal was detected in a punctuate distribution
throughout the thymus while in D1EnCKO thymi the Pecam1 dis-
tribution was much more dense, with a 5.03± 0.78-fold increase in
endothelial cell density over WT. Pecam1 expression was partic-
ularly strong in cortical areas and the sections contained many
ectopic medullary structures, several of which appeared to be
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FIGURE 5 | PlexinD1 on thymic endothelial cells regulates the
distribution of thymic medullary formations. (A) Schematic for analysis
of D1EnCKO cells on thymus development. Fetal thymi harboring WT
(both fused lobes transplanted) or D1EnCKO (single lobe transplanted)
endothelial cells were allowed to develop under the recipient’s renal
capsule. All cell populations in the transplanted D1EnCKO thymus other
than endothelial cells expressed plexinD1 appropriately as did all cells in
the normal recipients. (B) Red arrows in H&E stained panels indicate
regions of medulla fused with the thymic capsule. A frozen section
corresponding to the inset region in the D1EnCKO panel was stained for
keratin 8 highly represented in cTEC using the Troma1 antibody (56, 57)
and for ER-TR5 representing medullary development. Cortical-medullary
demarcation was confirmed by the relative representation of merged
CD4+CD8+ signal for DP cells and SP CD4 and CD8 cell development in
the subcapsular region. Result is representative of three independent
transplantation experiments. White bar in the confocal image represents
100µm and in the H&E stained image represents 5 mm. (C) Cryosections
of WT and D1EnCKO thymus were stained with anti-CD4-APC,
anti-CD8α-TRITC, and anti-ESAM mAb-FITC. Dashed yellow line follows
the corticomedullary junction; in the D1EnCKO panel, a second dashed
yellow line to the left indicates the ESAM+ cells in the subcapsullar zone.
C, cortex; M, medulla. Result is representative of three independent
transplantation experiments. White bar in the merged images are 100µm.
(D) Pecam1 staining to identify developing vascular endothelial structures.
High density nuclear staining by DAPI delineates cortical regions and lower
density nuclear staining correlates with medullary structures. C, cortex; M,
medulla. The corticomedullary junctions and capsules are identified by
dashed yellow lines. White bar in the images is 5 mm.
fused with the capsule. Thus the histological evidence for ectopic
medullary formation in the Plxnd1−/− thymi can be definitively
attributed to the expression of plexinD1 in thymic endothelial cells
and their essential function in thymic vascular development.
DISCUSSION
Through cell-type specific deletion of plexinD1 during thymic
organogenesis, we have dissected the involvement of plexinD1
and its ligand, sema3E, in thymic development dependent upon
thymocyte, epithelial, and vascular endothelial cell crosstalk for
proper organ pattern formation. We demonstrate that expression
of plexinD1 during the DP stage of thymocyte differentiation is a
necessary prerequisite for the orderly cortical to medullary translo-
cation that follows positive selection. In the absence of thymocyte
plexinD1, despite appropriate expression on all other cells in the
developing thymus, the activated CD69+ cells do not translocate
toward the medulla, instead largely remaining within the cortex.
Further, those mislocalized CD69+ cells initiate developmental
programing in local TEC cells in the cortex that induces the
ER-TR5 signal, a well characterized though molecularly undefined
marker of the mTEC environment and used to define medullary
locales. On the other hand, loss of plexinD1 in epithelial cells,
either cTEC or mTEC, was unremarkable and hence of no conse-
quence for any of the parameters monitored in the current study.
In contrast, loss of plexinD1 in the thymic endothelial prog-
enitor population led to distinct reorganization of thymic vas-
culature that was associated with ectopic medullary formation
in the cortex and a medulla topology characterized by fusion
with the capsule. We observed this phenotype previously in thymi
repopulated by Plxnd1 null cells (15). Thus thymic angiogenesis
attributable to endothelial progenitors in these Plxnd1−/− CKO
mice and earlier germline Plxnd1−/− KO progenitors determines
the locale of medulla formation. We further show that currently
accepted markers of mTEC are dynamically regulated since the
cortically localized CD69+ DP thymocytes in D1ThyCKO were
associated with increased cortical representation of ER-TR5 and
MHCII markers, but not UEA1. The latter remained associated
with the pre-formed, i.e., established,medullary structures. Finally,
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FIGURE 6 | Differential development of ESAM+ blood vessels inWT,
D1EnCKO and Sema3e−/− thymi. Thymic cryosections of the indicated
control mice and D1EnCKO (A) and Sema3e−/− (B) mice were stained with
anti-MHCII-APC, anti-CD8α-TRITC, and anti-ESAM mAb-FITC. Dashed line
follows the corticomedullary junction. The result is representative of one of
three independent experiments. The black bar below each merged image
represents 100µm and is applicable to every panel in each block. C, cortex;
M, medulla.
reinforcing the importance of the DP thymocytes in contributing
to the initial although transient establishment of medullary for-
mation, we demonstrate that DP activation in a Tcrb+/+Rag2−/−
thymus results in development of medullary regions populated
with SP thymocytes despite a genetic defect that precludes TCR
expression and allows only pre-TCR to be displayed on the surface
of DP thymocytes.
Our results clearly point to a dynamic interplay of thymo-
cyte differentiation and vascular localization. Both processes are
impacted by plexinD1 expression in independent cellular com-
partments, with consequent effects upon cTEC and mTEC func-
tion and medullary formation in turn effecting thymocyte differ-
entiation. Since the thymocytes migrate along a path governed by
differentiation-determined expression and function of chemokine
receptors (44, 45), it is reasonable to conclude that blocks on mat-
uration of thymocytes, exemplified here by loss of plexinD1, will
lead to significant aberrations in thymus morphology. This notion
is supported by results indicating that cTEC do not develop in
mice where the DN1→DN3 transition is defective (46) while a
block on SP thymocyte development leads to absence of medullary
formation, a state that can be altered by thymic influx of pas-
sively transferred SP T cells in SCID mice (34, 35). Collectively,
such observations argue that mature SP cells are required for
sustained medullary formation. In addition, we show here that
anti-CD3ε mAb triggered DP thymocytes can initiate differentia-
tion of medullary structures, even if located in ostensibly “cor-
tical” areas. Likewise, blocks in the orchestrated trafficking of
differentiating thymocytes also may lead to aberrations in thymic
morphology. For example, deficiency of CCR7 or of its ligands
CCL19/CCL21 results in thymocytes maintaining a cortical posi-
tion associated with ectopic medullary structure formation in the
subcapsular zone and spontaneous autoimmunity with increased
titers of circulating antibodies that lead to IgG deposition in renal
glomeruli (47, 48).
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The DP thymocytes constitute the major population in the
thymic cortex and we previously identified plexinD1 as a key reg-
ulator of DP thymocyte chemokine responses (15). In WT thymus
repopulated by Plxnd1−/− thymic precursors, we noted not only
the cortical retention of CD69+ (activated) DP cells confirmed
in this report in the D1ThyCKO mice, but also ectopic medullary
formations lying under the capsule. In the context of plexinD1’s
key role in controlling vascular development and branching (11,
20), we investigated the possibility that the fetal liver containing
early thymocyte progenitor cells used to repopulate the irradi-
ated thymi contained Plxnd1−/− endothelial precursors resulting
in aberrant thymic vasculature formation. As noted previously, the
development of the vascular bed in the thymus plays a key role in
organizing the medullary epithelial cell compartment (49). Since
D1EnCKO was neonatal lethal, we transplanted the D1EnCKO
thymi under the recipient renal capsule to follow development.
Under this circumstance, the abnormal fusion between thymic
capsule and medulla was observed, demonstrating that blood ves-
sel patterning directly affects the medulla location in thymus.
Unlike the vasculature of the WT thymus, ESAM+ blood vessels
exist under the thymic capsule of D1EnCKO mice. In thymi lacking
sema3E, however, a completely different phenotype was observed;
ESAM+ vessels were not observed under the thymic capsule but
instead found broadly distributed throughout the thymic cortex.
This discordance suggests that either plexinD1 may respond
to other thymic ligands distinct from sema3E, or that plexinD1
may contribute to intracellular regulatory pathways even in the
absence of extracellular sema3E-mediated stimulation. In addi-
tion to the regulation of plexinD1 expression by VEGF mentioned
above, the signaling for repulsion of developing neurites mediated
by sema3E signaling through plexinD1 is mitigated or reversed
by the ectodomain of neuropilin-1 (32). Of note, we observe no
evidence for any direct interaction of neuropilin-1 ectodomain
with either sema3E, plexinD1, or the sema3E-plexinD1 complex
(data not presented), suggesting regulation of plexinD1 function
by alternative signaling cascades mediated by Nrp1.
The apparently normal medullary structure and cortical-
medullary demarcation in D1ThyCKO thymus by histological
analysis in the context of a disorderly corticomedullary junc-
tion by confocal microscopy analysis point to a disengagement
of medullary processes required for normal thymic function. In
this report, we used ER-TR5 with or without UEA1 as another
medullary marker in addition to MHC class II expression (29–
31, 50). In general, the MHC class II expression correlated well
with that of ER-TR5. In the D1ThyCKO thymus, however, UEA1
remained associated with the histologically defined medulla while
ER-TR5 uncoupled from this signal and localized with the corti-
cally retained CD69+ DP thymocytes. Consequently, we propose
that ER-TR5 is not a medullary marker but should be considered
an epithelial cell marker induced by juxtaposition to developing
activated T lymphoid cells. This scenario seems more probable
than the suggestion that mTEC are rapidly migrating from the
established medulla into the cortex, although such a possibility
must be formally excluded in future studies.
An interesting corollary is that lack of plexinD1 on the DP
thymocytes does not inhibit the differentiation of the thymocytes
but only inhibits their migration. The involvement of plexinD1 as
a regulator of migration rather than differentiation is supported
strongly by similar functionality controlling migration not only
of thymocytes but also B cells, macrophages, osteoblasts, prostate
cancer cells, as well as colorectal tumor cell and melanoma cell line
metastasis in models in vivo (15, 16, 51–55). Control of migra-
tion has many facets, however, and may represent a regulation
of adhesion through integrins rather than migration itself. Cer-
tainly, in transwell migration assays in the absence of potential
interacting extracellular matrix components, we observe no effect
of plexinD1 loss upon thymocyte responses to either CXCL12
or CCL25 (Figure S2 in Supplementary Material) and we have
recently identified a direct role for plexinD1 independently as well
as in a sema3E-dependent manner for regulating integrin adhe-
sion (manuscript submitted). The additional role of plexinD1
in regulating thymic endothelial cell angiogenesis clearly has a
direct impact upon the location of medullary formations. In
this respect, it is of note that regional variations in thymic oxy-
genation are of critical importance for thymic structure as well
as possible influence upon selection processes during thymocyte
development (17–19).
CONCLUSION
The results presented herein represent a dissection of the simulta-
neous activities of the transmembrane receptor, plexinD1, func-
tioning in disparate developmental processes mediated by different
cellular compartments to regulate thymic organogenesis. PlexinD1
loss has a profound effect upon CD69+ positively selected DP thy-
mocyte trafficking. The mislocalization of this thymocyte subset
in the absence of gross alterations in thymic morphology impacts
markers previously believed to delineate the medullary compart-
ment. Meanwhile, loss of plexinD1 in vascular endothelial cells
during thymic development leads to a distinct rearrangement of
the thymic vascular structure that is clearly related to gross histo-
logical abnormalities in thymic morphology. In general, plexin
signaling activity has been viewed as relatively passive in the
absence of ligand. Comparison, however, of the thymus pheno-
types of the WT, D1EpCKO, D1ThyCKO, and Sema3e−/− null
mice lays the groundwork for examination of plexinD1 signal-
ing and functionality at the molecular level in both a sema3E
ligand-independent and sema3E-dependent fashion.
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Figure S1 shows that anti-CD3ε-induced apoptosis is iden-
tical for WT and D1ThyCKO thymocytes, and that within the
D1ThyCKO thymus, the number of developing CD69+ DP thy-
mocytes is not significantly different to that in WT thymus thus any
alteration in thymic localization represents a true positional shift
in the DP population. Figure S2 depicts the identical responses
of WT and D1ThyCKO cells to CXCL12 and CCL25 chemokines,
supporting the proposal that mislocalization of the latter pop-
ulation is due to alteration in guidance cue signaling rather
than an intrinsic defect in migratory capability. Figure S3 is a
direct supplement to Figure 2, showing the distribution of the
medullary UEA1 markers in the same thymic sections described
in Figure 2. Figure S4 quantifies the disengagement of cortical
ER-TR5 and MHC class II signal from canonical medullary struc-
tures observed in Figure 2. Figure S5 shows the development
of transient medullary structures next to ESAM+ blood vessels
in Tcrb+/+Rag2−/− mice injected with anti-CD3ε mAb. Figure
S6 reveals the disruption of association of ESAM+ vessels with
the corticomedullary junction in Sema3e−/− thymus. Figure S7
shows normal cortical and medullary thymic marker localiza-
tion in D1EnCKO thymus, even though some of the medullary
structures may be embedded in the cortex and close to the cap-
sule. Figure S8 demonstrates the dysregulation of vasculogenesis
in D1EnCKO newborn thymus revealed by staining for endothelial
cell Pecam1.
Figure S1 | Plxnd1 deletion does not affect apoptosis of, or CD69
expression on, thymocytes followingTCR stimulation. (A) One million total
thymocytes were stimulated with plate-coated anti-CD3ε mAb for the indicated
time period. After incubation, the cells were harvested and stained with
anti-CD4-APC/anti-CD8α-PE/anti-TCRβ-FITC mAbs and analyzed by flow
cytometry. The %live DP population was normalized against %live DP
population at 0 h. Error bars represent SEM. The result is representative of two
independent experiments. (B) After stimulation of total thymocytes for the
indicated time periods as in (A), the cells were harvested and stained with
anti-CD4-APC/anti-CD8α-PE/anti-CD69-FITC mAbs and analyzed by flow
cytometry. %CD69+ DP thymocytes was calculated relative to total DP
thymocytes. Error bars represent SEM. The result is representative of two
independent experiments.
Figure S2 | CXCL12- and CCL25-mediated migration is normal in
D1ThyCKO mice. Migration assays were performed with CXCL12 and CCL25
as described previously using both chemokines at 1µg/ml (15). After the
incubation for 2 h, the cells migrating across the transwell membrane into the
lower well were harvested and counted. White bars depict mock-treated (no
chemokine) control experiments. Error bars represent SEM.
Figure S3 | UEA1 expression in plexinD1 conditional knockout and
Sema3e−/− thymus. UEA1 expression in sections correlating to those depicted
in Figure 2 in the main article. Note that the bulk of UEA1 signal is medullary in
all cases. “M” defines medullary area, “C” defines cortical area; the dashed
line represents the corticomedullary junction, and the solid line represents the
thymic capsule.
Figure S4 | Quantitation of relative cortical and medullary ER-TR5 and
MHC class II expression in wt and D1ThyCKO thymi. The relative signals for
cortical and medullary-localized fluorescence were determined by image
analysis of six D1ThyCKO thymic sections and nine wt sections. For each
marker, the color image was converted to a grayscale image, six to seven
regions without apparent signal were selected to represent background and the
relative intensity for identically sized regions within areas demarcated as cortex
or medulla were determined using the ImageJ java suite. The D1ThyCKO
medullary MHC class II representation was significantly reduced on comparison
with wt (P <0.005) as was the medullary ER-TR5 representation (P <0.02).
Mean±SEM presented and compared using Student’s t -test.
Figure S5 | Co-localization of ESAM+ blood vessels and UEA1+ mTEC in
thymi ofTcrb+/+Rag2−/− mice injected with anti-CD3ε mAb. Adjacent
cryosections of each thymus were stained with the indicated Abs. anti-ESAM
was used to visualize endothelial cells and UEA1 to visualize mTEC. The
corticomedullary junction is indicated by the dashed line. The result represents
two independent analyses. White bar in the ESAM panels is 100µm and applies
to all panels.
Figure S6 | ESAM+ blood vessel distribution is normal in D1ThyCKO mice.
The thymic cryosections of the indicated mice were stained as described in
Figure 5C. The result is representative of three independent experiments. The
dashed line follows the corticomedullary junction where the demarcation
between cortex and medulla is based on the location of DP and SP thymocytes,
respectively. ESAM is an endothelial cell-specific marker. White bar in merged
image is 100µm. C, cortex; M, medulla.
Figure S7 | Normal CD69+ thymocyte distribution in transplanted D1EnCKO
mice. Adjacent cryosections of D1EnCKO thymi transplanted under the B6.SJL
renal kidney capsule were stained as described for Figure 2 and Figure S3. The
cortex (C) and the medulla (M) were divided based on the location of DP and SP
thymocytes. The left dashed line in each section follows the corticomedullary
junction and the right dashed line depicts the thymic capsule. White bar in
merged images is 100µm. The figure is representative of two independent
experiments. The graph depicts the enumeration of CD69+ cell density using
the FITC signal intensity as described in Figure 3. Sections from three
independent thymi were analyzed for each genotype (wt and D1EnCKO) and P
values were calculated using Student’s t -test where the ordinate axis depicts
the ratio of CD69+ cells in the medulla to CD69+ cells in the cortex. Error bars
represent SEM. The P value of 0.34 is not statistically significant.
Figure S8 | Pecam1+ endothelial cells are increased in newborn D1EnCKO
mice. (A) were collected from WT (n=2, “Control” in figure) and D1EnCKO
(n=3, “Mutant” in figure) newborn mice and fixed overnight in 10% formalin
solution, then stained for Pecam1 (CD31). (B)The overall intensity/area was
determined by image analysis for WT, and then both WT and D1EnCKO Pecam1
densities were expressed as a ratio of the WT values. Mean±SEM is depicted.
The white bar, applicable to all panels, represents 2 mm.
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